How to Buy Hemab Therapeutics Holdings Stock

Hemab Therapeutics Holdings Inc

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders.

Hemab Therapeutics Holdings stock last closed at $40.11, down 0.89% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Hemab Therapeutics Holdings stock is currently +74.39% from its 52-week low of $23.00, and -27.63% from its 52-week high of $55.42.

There are currently 46.71M shares of COAG outstanding. The market capitalization of COAG is $1.87B. In the past 24 hours, 257,000 COAG shares were traded.

How to Buy Hemab Therapeutics Holdings Stock

Wondering how to invest in Hemab Therapeutics Holdings stock? Here's how.

  1. Figure out where to buy Hemab Therapeutics Holdings stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Hemab Therapeutics Holdings stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Pick your method of payment and add your information.
  4. Evaluate Hemab Therapeutics Holdings stock: The Hemab Therapeutics Holdings ticker symbol is COAG. Is Hemab Therapeutics Holdings stock a good investment? Should you buy shares of COAG? How do COAG's underlying business fundamentals look? Do top analysts think Hemab Therapeutics Holdings is a good buy? Why has COAG's stock price moved recently? (Hint: Our stock research website can help you evaluate if COAG is a good stock to buy).
  5. Make your COAG purchase: Decide if you will purchase COAG shares at the current market price or use a limit order to purchase COAG stock at a given price.
  6. Get notifications regarding your investment in COAG: Create a watchlist to watch your investment in Hemab Therapeutics Holdings stock.

Step 1: Figure out where to buy Hemab Therapeutics Holdings stock

You need an online brokerage account to access the NASDAQ market and buy COAG shares.

A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in COAG today.

How to Create a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to start your new brokerage account.
  1. Send your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've finished signing up on the best stock app for beginners, you can securely and quickly fund your account:

Check out the video below to see the process of depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Hemab Therapeutics Holdings stock

After you have identified the best place to buy Hemab Therapeutics Holdings stock, it's important to analyze their stock before you invest, so you actually wrap your head around the risk and opportunity.

Hemab Therapeutics Holdings Numbers

COAG Price
$40.11
1w %
-10.01%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
4.12x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.87B
Next Earnings
N/A
Next Dividend
N/A

Hemab Therapeutics Holdings Fundamentals

WallStreetZen was built to help average investors perform better fundamental analysis in less time.

You can see all of the due diligence checks on COAG's stock page.

Is COAG stock undervalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge COAG's true value.

Using relative valuations measures:

  • COAG may be undervalued based on its P/B ratio of 4.12x, relative to Biotechnology industry P/B ratio of 5.24x

You can do more valuation analysis on COAG's stock here.

COAG Financials at a glance

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the COAG balance sheet.
  • COAG has a low debt to equity ratio of 0.03.
  • There are more short-term assets than short-term liabilities on the COAG balance sheet.

Is COAG stock a Buy, Hold, or Sell, according to analysts?

Out of 5 Wall Street analysts who give ratings on COAG, the consensus analyst rating on Hemab Therapeutics Holdings is a Strong Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Hemab Therapeutics Holdings stock forecast page.

COAG Technicals

SMA10
42.64
SMA20
45.67
SMA50
46.25
SMA100
N/A
SMA200
N/A
MACD
-1.82
MACD Signal
-0.87
MACD Histogram
-0.95
RSI
36.21
Stochastic %K
8.65
Stochastic %D
7.57
StochRSI %K
11.06
StochRSI %D
7.18

Who is buying/selling COAG?

In the last year, executives and large shareholders at COAG have bought more shares than they have sold.

Ra Capital Management LP, 10% Owner of COAG, was the latest COAG insider to buy. They bought $1,536,844.54 worth of COAG shares on Jun 16, 2026.

Get more info about who owns COAG stock here.

Can I get consistent income from COAG stock?

No, Hemab Therapeutics Holdings doesn't provide an income stream by paying out dividends.

Get analysis from other investors

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Make your COAG purchase

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally the best for newer investors.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific price limit, use a limit order.

Click the Open button and your broker will execute the order.

If you require more assistance investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get notifications regarding your investment in COAG

Now that you own some COAG stock, you'll want to stay up-to-date on your new shares.

Add COAG to a watchlist to see the latest developments about your COAG stock.

COAG Feed

How to Buy Stock in Hemab Therapeutics Holdings

To summarize, here are the 6 steps to buy Hemab Therapeutics Holdings stock:

  1. Figure out where to buy Hemab Therapeutics Holdings stock
  2. Create your brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Hemab Therapeutics Holdings stock
  5. Make your COAG purchase
  6. Get notifications regarding your investment in COAG

If you are looking for a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep tabs on your investment in Hemab Therapeutics Holdings, create a watchlist today.

NASDAQ: COAG
$40.11-0.36 (-0.89%)
Updated Sep 15, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: COAG
$40.11-0.36 (-0.89%)
Updated Sep 15, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Hemab Therapeutics Holdings share?

As of Sep 15, 2026, it costs $40.11 to buy one share of Hemab Therapeutics Holdings stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.249 shares of COAG.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Hemab Therapeutics Holdings stock?

According to 5 Wall Street analysts who monitor Hemab Therapeutics Holdings, their consensus recommendation is to buy Hemab Therapeutics Holdings stock.

What is the best way to buy Hemab Therapeutics Holdings stock?

One way to place an order for Hemab Therapeutics Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.